Hsu-Kai Huang

Dr. Hsu-Kai Huang

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
YHYi-Jhih Huang
Yi-Jhih Huang
KLKuan-Hsun Lin
Kuan-Hsun Lin
YCYing Yi Chen
Ying Yi Chen
TWTiHui Wu
TiHui Wu
HHHsu-Kai Huang
Hsu-Kai Huang
才H才旺 Tsai-Wang Huang
才旺 Tsai-Wang Huang

10 February 2020 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
HHHsu-Kai Huang
Hsu-Kai Huang
YHYi‐Jhih Huang
Yi‐Jhih Huang
KLKuan‐Hsun Lin
Kuan‐Hsun Lin
YCYing Yi Chen
Ying Yi Chen
KKKai‐Hsiung Ko
Kai‐Hsiung Ko
才H才旺 Tsai-Wang Huang
才旺 Tsai-Wang Huang

2 May 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PYPo-Jen Yun
Po-Jen Yun
GWGuan-Chyuan Wang
Guan-Chyuan Wang
YCYing Yi Chen
Ying Yi Chen
TWTiHui Wu
TiHui Wu
HHHsu-Kai Huang
Hsu-Kai Huang
才H才旺 Tsai-Wang Huang
才旺 Tsai-Wang Huang
The purpose of this study was to examine the impact of epidermal growth factor receptor (EGFR) mutation status and tyrosine kinase inhibitors (TKIs) on the survival of brain metastases (BM) in patients with surgically resected non-small cell lung cancer (NSCLC). We selected the patients who had developed metastatic NSCLC; analyzed the differences between brain metastases and other sites of metastases, including patient characteristics, EGFR status, and survival; and selected the patients who had BM for further investigation. We also compared the treatment effects of first-generation TKIs with those of second-/third-generation TKIs. A total of 785 cases of stage I-IIIa NSCLC were reviewed. Thirty-six (4.6%) patients were identified as having BM. Among them, 14 patients had a mutated EGFR status. No association between EGFR mutation and the incidence of BM was observed (p = 0.199). Patients with mutated EGFRs had significantly longer overall survival and post-recurrence survival than patients with wild-type EGFR mutation (p = 0.001 for both). However, there was no survival difference between patients with exon 19 and exon 21 mutations (p = 0.426). Furthermore, patients who received the second- and/or third-generation EGFR-TKIs had better survival than patients who only received first-generation EGFR-TKIs (p = 0.031). A multivariate analysis indicated that the next-generation TKIs (HR, 0.007; 95% CI, 0.000 to 0.556; p = 0.026) and a longer interval before BM development (HR, 0.848; 95% CI, 0.733 to 0.980; p = 0.025) were significant factors in longer survival. EGFR-TKIs were effective in treating NSCLC patients with BM after curative pulmonary surgery, especially in those patients harboring EGFR mutations. Furthermore, the second-/third-generation EGFR-TKIs showed more promising results than the first-generation EGFR-TKIs in treating those particular patients, though larger studies needed to further prove the results.

1 September 2017 in Journal of Thoracic Disease
Verified
Journal Article
Closed access
PDF file
YHYi-Jhih Huang
Yi-Jhih Huang
KLKuan-Hsun Lin
Kuan-Hsun Lin
TCTai-Kuang Chao
Tai-Kuang Chao
THTsai-Wang Huang
Tsai-Wang Huang
HHHsu-Kai Huang
Hsu-Kai Huang
Langerhans cell histiocytosis (LCH) is a rare disease with uncertain etiology that is more prevalent in children. LCH typically invades skeletal systems, but in rare cases, it has been reported in the ribs or sternum. Optimal treatment choices for single-site, skeletal LCH are still undefined. We report a case of adult-onset LCH of the sternum. The range of surrounding soft tissue invasion was confirmed by three-dimensional fusion and reconstruction of chest computed tomography and magnetic resonance images. Our patient was successfully treated by local surgical curettage and adjuvant radiation therapy. We concluded that postoperative adjuvant radiation therapy may be advantageous for single-site LCH of bones with soft tissue invasion.

14 October 2020 in Interactive CardioVascular and Thoracic Surgery
Verified
Journal Article
Closed access
YDYu-Ling Dai
Yu-Ling Dai
RHRen-Jun Hsu
Ren-Jun Hsu
HHHsu-Kai Huang
Hsu-Kai Huang
THTsai-Wang Huang
Tsai-Wang Huang
WTWen-Chiuan Tsai
Wen-Chiuan Tsai
KHKun-Lun Huang
Kun-Lun Huang
OBJECTIVES: An optimal ventilation strategy that causes as little mechanical stress and inflammation as possible is critical for patients undergoing pneumonectomy. The aim of this study was to determine whether adaptive support ventilation (ASV) can provide protective ventilation to the remaining lung after pneumonectomy with minimal mechanical stress and less inflammation than volume-control ventilation (VCV).METHODS: In this study, 15 pigs were randomly allocated to 3 groups (n = 5 for each group): the control group, the VCV group and the ASV group. After left pneumonectomy, the VCV group was treated with the volume-control set to 20 ml/kg, and the ASV group with the mode set to achieve 60% of the minute ventilation of 2 lungs.RESULTS: The ASV group had lower alveolar strain than the VCV group. The ASV group exhibited less lung injury and greater alveolar fluid clearance than the VCV group (13.3% vs −17.8%; P ≤ 0.018). Ventilator-induced lung injury was associated with changes in the cytokine levels in the exhaled breath condensate, differential changes in plasma and changes in the cytokines in the bronchoalveolar lavage fluid. Expression of 3 microRNAs (miR449b-3p, P ≤ 0.001; miR451-5p, P = 0.027; and miR144-5p, P = 0.008) was increased in the VCV group compared with the ASV group.CONCLUSIONS: The ASV mode was capable of supporting rapid, shallow breathing patterns to exert lung-protective effects in a porcine postpneumonectomy model. Further investigation of microRNAs as biomarkers of ventilator-induced lung injury is warranted.

1 January 2020 in Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
YHYaw-Don Hsu
Yaw-Don Hsu
HLHui-Chen Lin
Hui-Chen Lin
CHChang-Hsun Hsieh
Chang-Hsun Hsieh
FCFung-Wei Chang
Fung-Wei Chang
JLJiunn-Tay Lee
Jiunn-Tay Lee
HHHsu-Kai Huang
Hsu-Kai Huang
Background: In the past decade, Tri-Service General Hospital has trained many actors-background standardized patients (SPs). However, we also have recruited some nonactor SPs since 2010. Reviewing the literature, the reliability of SPs with or without actor background would be the impact factor on high-stakes OSCE has not been well studied. Aim: The purpose of this retrospective observation is to clarify whether a SP with or without a professional actor background will affect the performances of the examination when participating in the Taiwan high-stakes objective structured clinical examination (OSCE). The result will be the policy for selecting which kind of SPs to participate in the high-stack OSCE in our hospital. Methods: In this retrospective observation, we analyzed 74 actor background SPs (A-SPs), and 70 no actor background SPs (NA-SPs) who have participated in each spring test of 2015–2017 Taiwan high-stakes OSCE. The data of SPs performance have come from two parts: one is from the examinee with the global rating of the SPs performance and the other is from the examiner with eight-item checklist for the SPs performance. The scoring of both examinee and examiner is a five-point Likert scale. Results: The results show that there is no significant difference in SPs performance from the examinee scoring in the subsequent 3 years, stable and satisfactory, and let examinees feel like real patients. The scores from examiners also showed that two groups of SPs performed equally well without significant differences. Their performance is reliable and consistent, simulating to be a real patient in both groups. However, only one interest finding, when compared to the different age subdivision of SPs, showed the aged subgroup of A-SPs and NA-SPs with the significant difference in the item of reliability and consistent (4.67 ± 0.53 vs. 4.41 ± 0.50, P < 0.05), the possible reason is related to the less-experienced associate with mild memory decline in aged NA-SPs.Conclusions: Our observation gives the essential information, that the well-trained and experienced SP are necessary for participating in the high-stakes OSCE examination, even without the background of the actor. What we need is a professional SP who not only has excellent professionalism but also has a good personality literacy to engage in his/her work.